Group One Trading
EW icon

Group One Trading’s Edwards Lifesciences EW Stock Holding History

Group One Trading’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.36M Buy
66,900
+4,000
+6% +$330K 0.01% 1252
2025
Q4 		$5.36M Buy
62,900
+41,300
+191% +$3.39M 0.01% 1424
2025
Q3 		$1.68M Buy
21,600
+1,100
+5% +$85.9K ﹤0.01% 2491
2025
Q2 		$1.6M Sell
20,500
-9,700
-32% -$723K ﹤0.01% 2338
2025
Q1 		$2.19M Sell
30,200
-59,500
-66% -$4.26M 0.01% 1740
2024
Q4 		$6.64M Buy
89,700
+700
+0.8% +$49K 0.02% 958
2024
Q3 		$5.87M Buy
89,000
+72,800
+449% +$5.29M 0.02% 909
2024
Q2 		$1.5M Buy
16,200
+10,700
+195% +$948K 0.01% 1681
2024
Q1 		$526K Buy
5,500
+1,700
+45% +$143K ﹤0.01% 2676
2023
Q4 		$290K Sell
3,800
-2,200
-37% -$153K ﹤0.01% 3534
2023
Q3 		$416K Sell
6,000
-3,300
-35% -$265K ﹤0.01% 3093
2023
Q2 		$877K Buy
9,300
+2,100
+29% +$183K ﹤0.01% 2477
2023
Q1 		$596K Sell
7,200
-5,700
-44% -$448K ﹤0.01% 2597
2022
Q4 		$962K Buy
12,900
+8,700
+207% +$671K ﹤0.01% 2445
2022
Q3 		$347K Sell
4,200
-60,600
-94% -$5.83M ﹤0.01% 3587
2022
Q2 		$6.16M Buy
64,800
+27,800
+75% +$2.88M 0.01% 1146
2022
Q1 		$4.36M Sell
37,000
-79,400
-68% -$8.91M ﹤0.01% 1660
2021
Q4 		$15.1M Buy
116,400
+62,100
+114% +$7.24M 0.01% 830
2021
Q3 		$6.15M Buy
54,300
+6,000
+12% +$685K 0.01% 1484
2021
Q2 		$5M Buy
48,300
+2,000
+4% +$189K 0.01% 1690
2021
Q1 		$3.87M Buy
46,300
+23,900
+107% +$2.02M 0.01% 1789
2020
Q4 		$2.04M Sell
22,400
-7,700
-26% -$639K ﹤0.01% 2032
2020
Q3 		$2.4M Buy
30,100
+28,200
+1,484% +$2.2M 0.01% 1457
2020
Q2 		$131K Sell
1,900
-5,000
-72% -$355K ﹤0.01% 3702
2020
Q1 		$434K Sell
6,900
-11,700
-63% -$844K ﹤0.01% 2151
2019
Q4 		$1.45M Buy
18,600
+3,000
+19% +$234K 0.01% 1557
2019
Q3 		$1.14M Hold
15,600
– – 0.01% 1640
2019
Q2 		$961K Sell
15,600
-36,000
-70% -$2.18M 0.01% 1625
2019
Q1 		$3.29M Buy
51,600
+36,000
+231% +$2.05M 0.04% 641
2018
Q4 		$796K Sell
15,600
-50,100
-76% -$2.53M 0.01% 1669
2018
Q3 		$3.81M Buy
65,700
+2,100
+3% +$103K 0.03% 735
2018
Q2 		$3.09M Buy
63,600
+60,900
+2,256% +$2.84M 0.03% 818
2018
Q1 		$126K Sell
2,700
-65,700
-96% -$2.85M ﹤0.01% 3111
2017
Q4 		$2.57M Buy
68,400
+1,800
+3% +$66.1K 0.02% 1046
2017
Q3 		$2.43M Sell
66,600
-24,900
-27% -$950K 0.02% 917
2017
Q2 		$3.61M Buy
91,500
+17,700
+24% +$646K 0.04% 625
2017
Q1 		$2.31M Buy
73,800
+30,600
+71% +$958K 0.03% 778
2016
Q4 		$1.35M Buy
43,200
+6,900
+19% +$224K 0.01% 1138
2016
Q3 		$1.46M Sell
36,300
-4,800
-12% -$181K 0.02% 1022
2016
Q2 		$1.37M Buy
41,100
+9,600
+30% +$328K 0.02% 1037
2016
Q1 		$926K Buy
31,500
+21,000
+200% +$579K 0.01% 1232
2015
Q4 		$276K Sell
10,500
-16,500
-61% -$428K ﹤0.01% 2253
2015
Q3 		$640K Hold
27,000
– – 0.01% 1581
2015
Q2 		$641K Sell
27,000
-7,800
-22% -$176K 0.01% 1572
2015
Q1 		$826K Hold
34,800
– – 0.01% 1231
2014
Q4 		$739K Buy
34,800
+14,400
+71% +$289K 0.01% 1263
2014
Q3 		$347K Sell
20,400
-25,800
-56% -$407K 0.01% 1901
2014
Q2 		$661K Sell
46,200
-39,000
-46% -$529K 0.01% 1427
2014
Q1 		$1.05M Sell
85,200
-82,200
-49% -$948K 0.02% 1049
2013
Q4 		$1.83M Buy
167,400
+107,400
+179% +$1.21M 0.03% 700
2013
Q3 		$696K Sell
60,000
-2,400
-4% -$28.1K 0.01% 1305
2013
Q2 		$699K Buy
+62,400
New +$739K 0.02% 1088

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Group One Trading's EW Position: Q1 2026 in Review

Group One Trading opened a new position in Edwards Lifesciences (EW) in Q1 2026: 4,418 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #3655 among its holdings. This is a return to the name: Group One Trading previously reported a position in EW as recently as Q2 2025.

Group One Trading first reported a position in EW in Q2 2013 and has held it in 28 quarters since. The position peaked at $3.98M in Q4 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Group One Trading held 4,418 shares of Edwards Lifesciences worth $354K as of Q1 2026.
  • Edwards Lifesciences was a new Group One Trading position in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3655 holding.
  • Group One Trading first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 28 quarters since.
  • Group One Trading's Edwards Lifesciences position peaked at $3.98M in Q4 2024.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.